Physician profile
Thomas Robert Kroll
NPI 1114913472
$401.32
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $300 · 2020: $102.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $190.21 | 2019-2020 | |
| Maculogix, INC. | $48.57 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.44 | 2019 | |
| Alcon Research LLC | $31.24 | 2019 | |
| Alcon Vision LLC | $30.61 | 2020 | |
| Sun Pharmaceutical Industries INC. | $24.76 | 2020 | |
| Coopervision INC. | $22.76 | 2019 | |
| Allergan, INC. | $13.73 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Kroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.